Board Meeting Outcome

05 November 2026 BSE Limited Phiroze Jeejebhoy Towers, Dalal Street, Mumbai – 400001 Script Code: 543346 Dear Sir / Madam, Sub: Intimation under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Unaudited Financial Result for the Half Year ended on September 30, 2026 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“LODR Regulations”), the meeting of Board of Directors of the Company held today i.e. Thursday, 05 November, 2026 at 16:30 hours and concluded at 19:10 hours, and has inter alia considered and approved the Unaudited Financial Result for the Half Year ended on September 30, 2026, as recommended by the Audit Committee We request you to take this intimation on your records. Thanking you, Yours faithfully, For, Aashka Hospitals Limited Bipinchandra D. Shah Chairman & Managing Director DIN: 009348108 Encl.: a/a OM Parimal S. Shah & Co. Roigl o ur Under Opp. Muktajivan Photo, Cha rtered Accoun ka nts Navrangpura,Ahmedabad-380009., E-mail : parimal_vidhi@yahoo.com Phone : (079) 26460442, (M) 8980814999 Limited Review Report The Board of Directors, AASHKA HOSPITALS LIMITED We have reviewed the accompanying statement of unaudited standalone financial results of AASHKA HOSPITALS LIMITED (the "Company") for the Half Year ended on September 30, 2026 (the “statement”) attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations"). This statement is the responsibility of the Company’s Management and has been approved by the Board of Directors. Our responsibility is to issue a report on these financial statements based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For, Parimal S Shah & Co. Place: Ahmedabad Date: 05-11-2026 UDIN: 26038507XRDMGD6178 AASHKA HOSPITALS LIMITED Reg. Off.: Between Sargasan & Reliance Cross Roads, Sargasan, Gandhingar - 382421, Gujarat, India CIN: L85110GJ2012PLC072647 | E-mail: cs@aashkahospitals.in | Web: www.aashkahospitals.in Statement of Standalone unaudited Financial Results for the Half Year ended on September 30, 2026 (INR in Lakhs except for EPS) Half Year Ended Year Ended Particulars 30/09/2026 31/03/2026 30/09/2025 31/03/2026 (unaudited) (unaudited) (unaudited) (Audited) 1 Income from Operations (a) Net Income from Operation 1,481.40 1,256.66 1,044.37 2,301.03 (b) Other Income 113.95 1 96.21 30.70 226.91 Total Income from Operations (1) 1,595.35 1,452.87 1,075.07 2 ,527.94 2 Expenses (a) Cost of Materials consumed - - - - (b) Purchase of stock-in-trade 371.51 1 49.67 138.64 288.31 (c) Direct Expense - - - - (d) Changes in inventories of finished goods, work- (12.15) 3.64 (2.79) 0.85 in-progreess and stock in trade (e) Employee benefits expense 254.47 2 34.74 216.31 451.05 (f) Finance Costs 74.43 55.13 63.02 118.05 (g) Depreciation & Amortisation Expense 149.96 1 51.21 145.62 296.84 (h) Other Expenses 523.45 5 55.29 481.42 1,036.80 Total Expenses (2) 1,361.67 1,149.68 1,042.22 2 ,191.90 Profit / (Loss) before Exceptional & Extraordinary 3 233.68 303.19 32.85 336.04 Items & Tax (1-2) 4 Exeptional Items (61.71) - (59.57) (59.57) Profit / (Loss) before Extraordinary Items & Tax 5 295.39 303.19 92.42 395.61 (3-4) 6 Extraordinary Items - - - - 7 Profit / (Loss) before Tax (5-6) 295.39 303.19 92.42 395.61 8 Tax Expenses - MAT 46.08 47.30 14.42 6 1.71 9 Less: MAT Credit Entitlement - - - - 10 Profit / (Loss) after Tax (7-8+9) 249.31 255.89 78.00 333.90 Paid-up Equity Share Capital (face value of INR 10/- 11 234.00 2 34.00 233.68 234.00 each) Reserve & Surpluses (Excluding Revaluation 12 - - - 7,986.65 Reserve) 13 Earning per Share 1) Basic 1 .07 1.09 0.33 1.43 2) Diluted 1 .07 1.09 0.33 1.43 Notes: TheaboveresultswerereviewedbyAuditCommitteeandwereapprovedandtakenonrecordbyBoardofDirectorsat their meeting held on 05 November, 2026 Thefiguresofthepreviousperiodhavebeenregrouped/rearrangedwhere-evernecessary,tomakethemcomparable with those of the current period FiguresforthehalfyearendedMarch31,2026arethebalancingfiguresinrespecttothefullFinancialYearandthe 3 publishedyeartodatefiguresuptotheFirstHalfYearendedonSeptember30,2025oftherespectiveFinancialYear which were subject to the limited review 4 TheabovefinancialresultsareavailableonthewebsiteoftheCompanyi.e.www.aashkahospitals.inandonthewebsite of BSE Limited (SME Platform) i.e. www.bseindia.com 5 EPSiscalculatedasperAccountingStandard20consideringthesplitupofEquitySharesandaccordinglyEPSisadjusted for all the comparative periods presented TheCompanydoesnothavemorethanonereportable segmentintermsofAS-17(Segment Reporting).Hence, segment wise reporting is not applicable For, Aashka Hospitals Limited Bipinchandra D. Shah Date:05-Nov-26 Chairman & Managing Director Place:Gandhinagar DIN: 00934108 AASHKA HOSPITALS LIMITED Reg. Off.: Between Sargasan & Reliance Cross Roads, Sargasan, Gandhingar - 382421, Gujarat, India CIN: L85110GJ2012PLC072647 | E-mail: cs@aashkahospitals.in | Web: www.aashkahospitals.in Statement of Standalone Assets & Liabilities for the Half Year ended on September 30, 2026 (in INR Lakhs) Sr. 30/09/2026 31/03/2026 Particulars No. Unaudited Audited A EQUITY & LIABILITIES 1 Shareholder's Funds (a) Share Capital 2,340.00 2,340.00 (b) Reserves and Surplus 8,235.96 7,986.65 (c) Money received against Share Warrants - - Shareholder's Funds 1 0,575.96 10,326.65 2 Share application money pending allotment - - 3 Non - Current Liabilities (a) Long-term Borrowings 1,542.71 567.74 (b) Deferred tax liabilities (net) - - (c) Other long-term liabilities 50.40 50.40 (d) Long-term provisions 32.09 34.61 Non - Current Liabilities 1,625.20 652.75 4 Current Liabilities (a) Short Term Borrowings 42.51 255.74 (b) Trade Payables (i) Total oustanding dues of Micro & Small Enterprises 84.89 84.89 (ii) Total outstanding dues other than Micro & Small Enterprises 176.53 68.88 (c) Other current liabilities 49.86 89.73 (d) Short-term provisions 113.85 105.37 Current Liabilities 467.64 604.61 TOTAL - EQUITY & LIABILITIES (A) 1 2,668.81 11,584.01 B ASSETS 1 Non - Current Assets (a) Fixed Assets 4,168.61 4,152.03 (b) Non - Current Investments - - (c) Deferred tax assets (net) - - (d) Long-term loans and advances - - (e) Other non - current assets 6,640.94 5,740.26 Non - Current Assets 10,809.56 9,892.29 2 Current Assets (a) Current Investments - - (b) Inventories 51.06 38.91 (c) Trade Receivables 991.96 696.81 (d) Cash & Cash Equivalents 194.26 432.29 (e) Short-term loans and advances 5.27 5.27 (f) Other Current Assets 616.71 518.44 Current Assets 1,859.25 1,691.72 TOTAL - ASSETS (B) 12,668.81 11,584.01 For, Aashka Hospitals Limited Bipinchandra D. Shah Date:05-Nov-26 Chairma [Showing first 8,000 characters — download PDF for full document]